Crop Life Science Ltd.

As of March 31, 2026, Crop Life Science Ltd. carries a market capitalization of 702.74M, placing it among publicly traded companies globally. Its enterprise value stands at 1.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Crop Life Science Ltd. has 17.14M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Crop Life Science Ltd. maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Crop Life Science Ltd.'s stock has gained approximately 35.24% over the past 52 weeks. The 50-day moving average sits at 72.77, while the 200-day moving average is 55.55.

As of March 31, 2026, Crop Life Science Ltd. holds 34.82M in cash and equivalents against 565.67M in total debt, resulting in a net debt position of 523.58M. Total book value stands at 842.46M, with working capital of 628.37M providing operational flexibility.